~~<i id='88E64165E1'><strike id='88E64165E1'><tt id='88E64165E1'><pre id='88E64165E1'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

explore

author：Wikipedia 2025-09-28 00:47:57 - browse：497

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Secretariat’s lessons for human medicine

focus

leisure time

hotspot

explore

focus

INAFASSBENDER/AFPviaGettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup tog

WSS

As AI regulations shape up, health tech startups beg for clarity

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Medicare Advantage enrollment grows 7.1% to 33.4 million people

As AI regulations shape up, health tech startups beg for clarity

Researchers on aging grapple with how to calculate biological age

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

hotspot

explore

focus

23andMe had bad news about my health. I wish a person had delivered it

Study: Adult vaccinations pay for themselves in societal benefits

Supreme Court strikes down use of affirmative action

Steward Health Care files for bankruptcy

United colonoscopy coverage change 'may cost lives,' doctors say

In 'major milestone,' FDA approves first cell therapy for solid tumors

Sports medicine is finally prioritizing gender equality

WATCH: Why do our ears pop?

Peter Hotez and the public health issue of online harassment

Use wet bulb globe temperature, not heat index, to protect workers

leisure time

Hospitals are piloting generative AI tools as regulators play catch

First recipient of genetically engineered pig kidney has died

Study: AI not yet building 'n

Flagship Pioneering startup Sonata Therapeutics lays off 21

Weight loss drugs aren’t covered by Obamacare. That may change

Flagship Pioneering startup Sonata Therapeutics lays off 21

hotspot

explore

focus

focus